Aortic valve area: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


==Cardiac Catheterization==
==Cardiac Catheterization==
Simultaneous measurement of [[Cardiac output|left ventricular output]] ''(measures the flow through the aortic valve)'' and the [[Intravascular pressure gradient|pressure gradient]] across the aortic valve provides the essential variables that is required to calculate the aortic valve area and resistance.<ref>Hirshfeld JW, Kolansky DM. Valve function: Stenosis and regurgitation. In: Diagnostic and Therapeutic Cardiac Catheterization, 2nd ed, Pepine CJ, Hill JA, Lambert CR (Eds), Williams & Wilkins, Baltimore 1994. p.443</ref><ref>Carabello BA, Grossman W. Calculation of stenotic valve orifice area. In: Cardiac Catheterization and Angiography, 3rd ed, Grossman W (Ed), Lea and Febiger, Philadelphia 1986. p.143.</ref>
*Simultaneous measurement of [[Cardiac output|left ventricular output]] ''(measures the flow through the aortic valve)'' and the [[Intravascular pressure gradient|pressure gradient]] across the aortic valve provides the essential variables that is required to calculate the aortic valve area and resistance.<ref>Hirshfeld JW, Kolansky DM. Valve function: Stenosis and regurgitation. In: Diagnostic and Therapeutic Cardiac Catheterization, 2nd ed, Pepine CJ, Hill JA, Lambert CR (Eds), Williams & Wilkins, Baltimore 1994. p.443</ref><ref>Carabello BA, Grossman W. Calculation of stenotic valve orifice area. In: Cardiac Catheterization and Angiography, 3rd ed, Grossman W (Ed), Lea and Febiger, Philadelphia 1986. p.143.</ref>  
 
*According to the current recommendations, following [[dobutamine|dobutamine infusion]], if the aortic valve area increases to >1.2 cm<sup>2</sup>, and the mean pressure gradient rises above 30 mmHg, such patients may benefit from [[aortic valve replacement]]. Failure to achieve these improvements has shown to be associated with higher early surgical mortality in comparison to patients who can augment their contractility and gradient: '''32-33% versus 5-7%''', respectively. Additionally, 5-year survival was lower in patients who could not augment their contractility in comparison to those who could: '''10–25% versus 88%''', respectively.


===Aortic Valve Area:===
===Aortic Valve Area:===

Revision as of 19:28, 12 April 2012

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic valve area On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic valve area

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic valve area

CDC on Aortic valve area

Aortic valve area in the news

Blogs on Aortic valve area

Directions to Hospitals Treating Aortic valve area

Risk calculators and risk factors for Aortic valve area

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Normal aortic valve offers little or no resistance to the blood flow across the valve despite the high flow velocities. With progressive aortic stenosis, the aortic valve orifice offers progressively greater resistance to the blood flow through the valve with subsequent reduction in the pressure gradient between the left ventricle and the aorta. Therefore, using both the pressure gradient across the valve and the surface area of the valve the severity of aortic stenosis can be estimated. The latter can be calculated using echocardiographic flow velocities while the trans-valvular pressure gradient can be calculated using the following equation:

Pressure Gradient = 4 x (velocity of blood through the valve)2 mmHg

However, the absence of a large gradient across the aortic valve does not exclude the presence of critical aortic stenosis as evidenced by the presence of low gradient, low ejection and subsequent low flow aortic stenosis that is associated with poor clinical outcomes. Therefore, it is for this reason that the best measure of the severity of aortic stenosis is the aortic valve area and not the aortic valve gradient.

Cardiac Catheterization

  • Simultaneous measurement of left ventricular output (measures the flow through the aortic valve) and the pressure gradient across the aortic valve provides the essential variables that is required to calculate the aortic valve area and resistance.[1][2]
  • According to the current recommendations, following dobutamine infusion, if the aortic valve area increases to >1.2 cm2, and the mean pressure gradient rises above 30 mmHg, such patients may benefit from aortic valve replacement. Failure to achieve these improvements has shown to be associated with higher early surgical mortality in comparison to patients who can augment their contractility and gradient: 32-33% versus 5-7%, respectively. Additionally, 5-year survival was lower in patients who could not augment their contractility in comparison to those who could: 10–25% versus 88%, respectively.

Aortic Valve Area:

Aortic valve area can be calculated by the following two equations:

Gorlin Equation:

Aortic Valve Area (cms2) = (Stroke volume (mL/beat) ÷ Systolic ejection period (secs/beat)) ÷ ( 44.3 x square root of mean systolic pressure gradient between the left ventricle and aorta (mmHg))

Hakki Equation:

Aortic Valve Area (cms2) = (Cardiac output (liters/minute)) ÷ (Square root of mean systolic pressure gradient between the left ventricle and aorta (mmHg))

Aortic Valve Resistance:

  • Furthermore, aortic valve resistance is less flow-dependent than aortic valve area which is of particular benefit in patients with low output aortic stenosis.[3]
  • Aortic valve resistance can be calculated using the equation:

Aortic Valve Resistance (dyne seconds per cms5) = { (Mean Pressure Gradient between the left ventricle and aorta (mmHg) x Heart Rate (beats/min) x Systolic ejection period (secs/beat) ) ÷ Cardiac output } x 1.33

References

  1. Hirshfeld JW, Kolansky DM. Valve function: Stenosis and regurgitation. In: Diagnostic and Therapeutic Cardiac Catheterization, 2nd ed, Pepine CJ, Hill JA, Lambert CR (Eds), Williams & Wilkins, Baltimore 1994. p.443
  2. Carabello BA, Grossman W. Calculation of stenotic valve orifice area. In: Cardiac Catheterization and Angiography, 3rd ed, Grossman W (Ed), Lea and Febiger, Philadelphia 1986. p.143.
  3. 3.0 3.1 Cannon JD, Zile MR, Crawford FA, Carabello BA (1992). "Aortic valve resistance as an adjunct to the Gorlin formula in assessing the severity of aortic stenosis in symptomatic patients". Journal of the American College of Cardiology. 20 (7): 1517–23. PMID 1452925. Retrieved 2012-04-12. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources